Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I
Summary
The Drug Enforcement Administration (DEA) is proposing to classify MDMB-4-PINACA, a synthetic drug similar to marijuana, as a Schedule I controlled substance, making it illegal to manufacture, distribute, or possess. This designation reflects serious health and safety concerns about the drug's effects and potential for abuse.
Key Points
- 1MDMB-4-PINACA would become a Schedule I drug, the most restricted category, meaning it has no accepted medical use and high potential for abuse
- 2Manufacturing, selling, or possessing this drug would become a federal crime with criminal penalties including fines and imprisonment
- 3The public has until November 4, 2025, to submit comments to the DEA about whether this regulation should be adopted
- 4This drug is a synthetic cannabinoid (sometimes called 'K2' or 'spice') that produces effects similar to marijuana but can be significantly more dangerous
- 5Law enforcement and drug treatment programs will focus enforcement resources on stopping the distribution and use of this substance
Key Dates
October 2, 2025
This summary is for informational purposes only. It may not capture all nuances of the regulation. Always refer to the official text for authoritative information.
The Digest Network
AI Comment Drafter
Describe your concern and we'll help you draft a substantive comment.
AI-generated draft. Always review and edit before submitting. Replace all [bracketed placeholders] with your specific details. Your comment should reflect your genuine views and experience.